logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Makoto Maemondo

jichi medical university

46H指数
304论文数
1.6W被引数
收录论文 74
发表时间
logo
Negative-pressure pumping fluid as a cytological specimen for bronchoscopic diagnosis and molecular testing in lung cancer负压抽吸液作为支气管镜诊断和肺癌分子检测的细胞学标本
errLung Cancer
IF4.4
err2026-07-01
err0
PREAI
errNakayama, Masayuki; Takasaki, Toshikazu; Yanagita, Miki; Suzuki, Tomoko; Takigami, Ayako; Yamauchi, Hiroyoshi; Kurosaki, Fumio; Hisata, Shu; Mato, Naoko; Yamamoto, Shinichi; Bando, Masashi; Hagiwara, Koichi; Fujita, Kazutaka; Maemondo, Makoto
err分享
err收藏
Immune-mediated inflammatory diseases associated with sarcoidosis: A case-control study in Japan与结节病相关的免疫介导性炎症性疾病：一项在日本进行的病例对照研究
errRESPIRATORY MEDICINE
IF3.1
err2025-12-01
err0
PREAI
errTsukao, Hitokazu; Sawahata, Michiru; Arai, Naoto; Kamei, Ryohei; Tamada, Tsutomu; Shijubo, Noriharu; Yamaguchi, Tetsuo; Ishihara, Mami; Hattori, Takeshi; Konno, Satoshi; Agematsu, Ryuji; Takiguchi, Shunichi; Konnai, Minori; Nagaoka, Tadashi; Kurihara, Shuichi; Watanabe, Teruki; Kosami, Koki; Nakamura, Yoshikazu; Bando, Masashi; Hagiwara, Koichi; Maemondo, Makoto
err分享
err收藏
A Transcriptomic Analysis of Cancer-Stromal Interactome in Lung Cancer Xenograft Models肺癌异种移植模型中癌-基质互作组的转录组分析
errCANCER SCIENCE
IF4.3
err2025-12-01
err0
errOAAI
errTakayama-isagawa, Yuriko; Komura, Daisuke; Isagawa, Takayuki; Amano, Yusuke; Kihara, Atsushi; Miura, Tamaki; Yoshimoto, Taichiro; Tsubochi, Hiroyoshi; Fujita, Kazutaka; Hagiwara, Koichi; Maemondo, Makoto; Ushiku, Tetsuo; Ishikawa, Shumpei; Fukushima, Noriyoshi; Inamura, Kentaro; Matsubara, Daisuke; Niki, Toshiro
err分享
err收藏
Life-threatening airway stenosis due to Scedosporium infection during nontuberculous mycobacteria treatment: A case report
errRespiratory Medicine Case Reports
IF0.7
err2025-10-01
err0
errOAAI
errKurosaki, Ayako; Mato, Naoko; Iijima, Akinaga; Nakayama, Masayuki; Yamamoto, Shinichi; Bando, Masashi; Maemondo, Makoto
err分享
err收藏
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial度鲁妥单抗、卡铂和依托泊苷用于治疗初治广泛期小细胞肺癌且体力状况较差的患者（NEJ045A）：一项单臂Ⅱ期试验
errThe Lancet Respiratory Medicine
IF32.8
err2025-09-28
err0
PREAI
errTetsuhiko Asao; Yu Saida; Satoshi Watanabe; Akira Kisohara; Kazuma Kishi; Ryo Morita; Taku Nakagawa; Yoko Tsukita; Naoki Furuya; Taichi Miyawaki; Nobuhisa Ishikawa; Tadaaki Yamada; Takahiro Tanaka; Satoshi Morita; Toshiaki Kikuchi; Makoto Maemondo; Kunihiko Kobayashi
err分享
err收藏
A Phase 2 study of osimertinib in combination with platinum-pemetrexed in patients with uncommon epidermal growth factor receptor-mutated advanced non-small cell lung cancer (NEJ067/OPAL2)一项奥希替尼联合铂类-培美曲塞治疗 uncommon epidermal growth factor receptor-mutated advanced non-small cell lung cancer（NEJ067/OPAL2）的II期研究
errClinical Lung Cancer
IF3.3
err2025-08-26
err0
PREAI
errDaisuke Morinaga; Megumi Furuta; Satoshi Morita; Eisaku Miyauchi; Kunihiko Kobayashi; Makoto Maemondo; Hajime Asahina
err分享
err收藏
A phase II study of afatinib in combination with pemetrexed and carboplatin in patients with EGFR mutation-positive non-squamous, advanced non-small cell lung cancer (NSCLC) refractory to first-line osimertinib treatment: NEJ025B Study一项关于阿法替尼与培美曲塞和卡铂联合治疗EGFR突变阳性、非鳞状、晚期非小细胞肺癌（NSCLC）患者（对一线奥希替尼治疗耐药）的II期研究：NEJ025B研究
errEuropean Journal of Cancer
IF7.1
err2025-08-20
err0
PREAI
errHiromi Nagashima; Tatsuro Fukuhara; Yu Utsumi; Aya Suzuki; Akihiko Miyanaga; Masahiro Seike; Koichi Azuma; Hajime Asahina; Akira Kisohara; Yosuke Kawashima; Hisashi Tanaka; Ryota Kanemaru; Eisaku Miyauchi; Naoki Furuya; Haruna Sato; Kazuhisa Nakashima; Satoshi Watanabe; Kazuko Sakai; Kazuto Nishio; Fumiaki Takahashi; Kunihiko Kobayashi; Makoto Maemondo
err分享
err收藏
Latent microbial reactivation and immune dysregulation in sarcoidosis: bridging pathogenesis and precision therapeutics结节病中的潜伏微生物再激活和免疫失调：连接发病机制和精准治疗
errFrontiers in Medicine
IF3
err2025-08-15
err0
errOAAI
errMichiru Sawahata; Keisuke Uchida; Asuka Furukawa; Yoshinobu Eishi†; Makoto Maemondo
err分享
err收藏
Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysisDurvalumab在表皮生长因子受体突变型III期非小细胞肺癌患者接受同步化放疗后的应用：一项日本真实世界数据分析
errLung Cancer
IF4.4
err2025-05-27
err0
errOAAI
errToshiya Fujisaki; Eisaku Miyauchi; Gen Kida; Yu Miura; Kana Watanabe; Hironori Ashinuma; Motohiro Tamiya; Hajime Kikuchi; Daisuke Arai; Satoshi Takahashi; Ken Masuda; Ayako Takigami; Yoshiaki Nagai; Taichi Miyawaki; Yukari Tsubata; Akira Nakao; Ken Masubuchi; Kazuhiro Nishiyama; Satoshi Watanabe; Satoshi Morita; Makoto Maemondo
err分享
err收藏
The diagnostic value of comprehensive next-generation sequencing for genetic mutations in suspected lung cancer cases with negative pathological cytology综合二代测序技术对病理细胞学阴性疑似肺癌患者基因突变的诊断价值
errLUNG CANCER
IF4.4
err2025-04-01
err0
errOAAI
errGoto, Yuka; Watanabe, Satoshi; Yanagimura, Naohiro; Arita, Masashi; Sato, Miyuki; Nozaki, Koichiro; Tanaka, Tomohiro; Saida, Yu; Maemondo, Makoto; Kobayashi, Kunihiko; Hagiwara, Koichi; Kikuchi, Toshiaki
err分享
err收藏
A novel bioassay reflecting response to immune checkpoint inhibitor therapy in non-small cell lung cancer with malignant pleural effusion
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2024-12-01
err0
errOAAI
errTakigami, Ayako; Mato, Naoko; Hagiwara, Koichi; Maemondo, Makoto
err分享
err收藏
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A
errESMO OPEN
IF8.3
err2024-10-01
err1
errOAAI
errMouri, A.; Kisohara, A.; Morita, R.; Ko, R.; Nakagawa, T.; Makiguchi, T.; Isobe, K.; Ishikawa, N.; Kondo, T.; Akiyama, M.; Bessho, A.; Honda, R.; Yoshimura, K.; Kagamu, H.; Kato, S.; Kobayashi, K.; Kaira, K.; Maemondo, M.
err分享
err收藏
ASO Visual Abstract: Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2023-12-12
err0
errOAAI
errShikanai, Shunsuke; Yamada, Noriyuki; Yanagawa, Naoki; Sugai, Mayu; Osakabe, Mitsumasa; Saito, Hajime; Maemondo, Makoto; Sugai, Tamotsu
err分享
err收藏
LIGHT-NING 2nd interim analysis: Early safety of 1L nivolumab plus ipilimumab plus /- chemotherapy for NSCLC in Japan
errANNALS OF ONCOLOGY
IF65.4
err2023-11-01
err1
errOAAI
errAzuma, Koichi; Imai, Hisao; Kijima, Takashi; Kishi, Kazuma; Saito, Haruhiro; Yamaguchi, Teppei; Hayashi, Hidetoshi; Shiraishi, Yoshimasa; Fujita, Kohei; Watanabe, Satoshi; Kitazono, Satoru; Fukuhara, Tatsuro; Hataji, Osamu; Toi, Yukihiro; Mizutani, Hideaki; Hamakawa, Yusuke; Maemondo, Makoto; Ohsugi, Tomoyuki; Suzuki, Keisuke; Horinouchi, Hidehito; Ohe, Yuichiro
err分享
err收藏
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety
errBIOMEDICINES
IF3.9
err2023-09-10
err3
errOAAI
errFukuhara, Tatsuro; Imai, Kazuhiro; Nakagawa, Taku; Igusa, Ryotaro; Yokota, Hayato; Watanabe, Kana; Suzuki, Aya; Morita, Mami; Onodera, Ren; Inoue, Akira; Miura, Masatomo; Minamiya, Yoshihiro; Maemondo, Makoto
err分享
err收藏
Characteristics and prognostic analysis of patients with detected KRAS mutations in resected lung adenocarcinomas by peptide nucleic acid-locked nucleic acid polymerase chain reaction (PNA-LNA PCR) clamp method
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2023-09-01
err1
errOAAI
errHashimoto, Tatsuya; Owada, Yoshihisa; Katagiri, Hiroshi; Yakuwa, Kazuhiro; Tyo, Katuya; Sugai, Mayu; Fuzimura, Itaru; Utsumi, Yu; Akiyama, Masachika; Nagashima, Hiromi; Terasaki, Hitoshi; Yanagawa, Naoki; Saito, Hajime; Sugai, Tamotsu; Maemondo, Makoto
err分享
err收藏
Prognostic Impact of Tumor-Associated Macrophage-Related Markers in Patients with Adenocarcinoma of the Lung
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2023-06-06
err5
errOAAI
errShikanai, Shunsuke; Yamada, Noriyuki; Yanagawa, Naoki; Sugai, Mayu; Osakabe, Mitsumasa; Saito, Hajime; Maemondo, Makoto; Sugai, Tamotsu
err分享
err收藏
Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR plus non-small-cell lung cancer
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2023-06-01
err3
errOAAI
errNishio, Makoto; Atagi, Shinji; Goto, Koichi; Hosomi, Yukio; Seto, Takashi; Hida, Toyoaki; Nakagawa, Kazuhiko; Yoshioka, Hiroshige; Nogami, Naoyuki; Maemondo, Makoto; Nagase, Seisuke; Okamoto, Isamu; Yamamoto, Noboru; Igawa, Yuriko; Tajima, Kosei; Fukuoka, Masahiro; Yamamoto, Nobuyuki; Nishio, Kazuto
err分享
err收藏
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS)
errCLINICAL LUNG CANCER
IF3.3
err2023-06-01
err5
errOAAI
errMiyanaga, Akihiko; Asahina, Hajime; Watanabe, Satoshi; Shukuya, Takehito; Tsubata, Yukari; Hosomi, Yukio; Sugawara, Shunichi; Maemondo, Makoto; Okano, Tetsuya; Morita, Satoshi; Matsuyama, Kotone; Kobayashi, Kunihiko; Seike, Masahiro
err分享
err收藏
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study奥希替尼联合铂类和培美曲塞治疗未经治疗的EGFR突变的晚期非鳞状非小细胞肺癌患者的2期研究: OPAL研究
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2023-05-01
err15
errOAAI
errSaito, Ryota; Sugawara, Shunichi; Ko, Ryo; Azuma, Koichi; Morita, Ryo; Maemondo, Makoto; Oizumi, Satoshi; Takahashi, Kazuhisa; Kagamu, Hiroshi; Tsubata, Yukari; Seike, Masahiro; Kikuchi, Toshiaki; Okamoto, Isamu; Satoshi, Morita; Asahina, Hajime; Tanaka, Kentaro; Sugio, Kenji; Kobayashi, Kunihiko
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
James Chih‐Hsin Yang
H 指数: 141 · 论文数: 1.2K
Y
Yi‐Long Wu
H 指数: 135 · 论文数: 2.2K
T
Tony Mok
H 指数: 131 · 论文数: 1.1K
K
Kouji Matsushima
H 指数: 130 · 论文数: 787
S
Suresh S. Ramalingam
H 指数: 124 · 论文数: 1.2K
查看更多